Amylyx Pharmaceuticals Inc (AMLX)
2.03
+0.03
(+1.50%)
USD |
NASDAQ |
May 03, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price to Book Value: 0.3175 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 0.3175 |
May 02, 2024 | 0.3128 |
May 01, 2024 | 0.3018 |
April 30, 2024 | 0.2831 |
April 29, 2024 | 0.2971 |
April 26, 2024 | 0.2752 |
April 25, 2024 | 0.2784 |
April 24, 2024 | 0.294 |
April 23, 2024 | 0.305 |
April 22, 2024 | 0.3096 |
April 19, 2024 | 0.2924 |
April 18, 2024 | 0.3096 |
April 17, 2024 | 0.3128 |
April 16, 2024 | 0.3143 |
April 15, 2024 | 0.3237 |
April 12, 2024 | 0.3284 |
April 11, 2024 | 0.3581 |
April 10, 2024 | 0.3847 |
April 09, 2024 | 0.4175 |
April 08, 2024 | 0.4207 |
April 05, 2024 | 0.4097 |
April 04, 2024 | 0.4082 |
April 03, 2024 | 0.4113 |
April 02, 2024 | 0.4097 |
April 01, 2024 | 0.4238 |
Date | Value |
---|---|
March 28, 2024 | 0.4441 |
March 27, 2024 | 0.4504 |
March 26, 2024 | 0.4285 |
March 25, 2024 | 0.4238 |
March 22, 2024 | 0.4285 |
March 21, 2024 | 0.4488 |
March 20, 2024 | 0.4645 |
March 19, 2024 | 0.4582 |
March 18, 2024 | 0.4473 |
March 15, 2024 | 0.5067 |
March 14, 2024 | 0.4957 |
March 13, 2024 | 0.538 |
March 12, 2024 | 0.538 |
March 11, 2024 | 0.5943 |
March 08, 2024 | 0.5255 |
March 07, 2024 | 2.967 |
March 06, 2024 | 2.979 |
March 05, 2024 | 2.948 |
March 04, 2024 | 2.993 |
March 01, 2024 | 2.926 |
February 29, 2024 | 2.948 |
February 28, 2024 | 3.060 |
February 27, 2024 | 2.971 |
February 26, 2024 | 2.746 |
February 23, 2024 | 2.760 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2752
Minimum
Apr 26 2024
18.06
Maximum
Dec 01 2022
5.537
Average
3.998
Median
Price to Book Value Benchmarks
Cassava Sciences Inc | 6.933 |
iRhythm Technologies Inc | 15.14 |
Bristol-Myers Squibb Co | 5.408 |
Moderna Inc | 3.738 |
ACADIA Pharmaceuticals Inc | 6.507 |
Price to Book Value Related Metrics
PE Ratio | 2.90 |
PS Ratio | 0.3735 |
Price to Free Cash Flow | 13.32 |
Price | 2.03 |
Earnings Yield | 34.48% |
Market Cap | 137.60M |
Operating PE Ratio | 3.666 |
Normalized PE Ratio | 2.90 |